O4 Hubs detail
O4 Detail Hero Banner


Will these 4 new drugs re-shape the market?

Get the latest in this quarter’s Drug Pipeline Insights Report.

By Sumit Dutta, MD, Chief Medical Officer at Optum Rx­ | Published: March 2022

O4 1 Column (Full)
O4 2 Columns (1/4 - 3/4)
O4 Text Component

In this latest Drug Pipeline Insights Report, Optum Rx highlights the four medications expected by the end of the second quarter of 2022. While these new drugs might be safer and more effective, they come at a cost.

The drugs in this report include treatments for:

  • A rare heart condition
  • Plaque psoriasis
  • Type 2 diabetes
  • A cardiovascular disease characterized by an abnormally thick heart muscle
O4 Text Component
O4 Text Component

Don't want to read the full report? Download the brief summary.

O4 Text Component

Related content

O4 Complex Card

4 more psoriasis drugs on the way

Psoriasis costs up 40% in 5 years. Will these drugs help?
O4 Complex Card

5 questions: Optum Rx chief pharmacy officer

Michael Einodshofer addresses the risks, challenges and opportunities facing the industry.
O4 Complex Card

Learn how we can help solve your challenges